Florian Vincent

Mac-Lloyd is a growing company. With a strong client base in France, Mac-Lloyd has now invested internationally to boost its growth. Mac-Lloyd is specialized in GPS tracker for Baseball, Soccer, Football, Basketball, Rugby and Ice Hockey. Based in Paris, Miami, Rosario, Auckland and Kiev.

Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM®, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, “universal” influenza candidate, OVX836, which is currently in Phase 2 clinical trials with over 1200 subjects tested and encouraging efficacy proof of concept data. Osivax’ ambition is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of sarbecovirus in one single shot. The company will expand into other infectious disease indications through combinations and collaborations worldwide.

Novolyze empowers food and beverage companies to enhance food safety and quality performance and compliance in a rapidly changing environment. We offer application-driven, tech-enabled solutions to activate a groundbreaking, holistic approach to food safety and quality. We leverage the power of IoT and cloud computing to unify food safety and quality data, transform them into actionable insights, and enable real-time decision-making.

The Sport Heroes page is not active anymore >>> Please consult the United Heroes page at https://www.linkedin.com/company/28998290. Sport Heroes is the creator of the Running, Cycling, Swimming and United Heroes apps. The company name changed for "United Heroes" in Dec 2024. United Heroes is the European leader in driving Employee Engagement in the workplace leveraging sense of community and belonging. Created in 2014 and part of the ‘HR Tech’ solutions, this app helps companies to engage all their employee profiles, regardless of their job or geographical location. Since its inception, United Heroes has worked with +1000 organisations (Paris 2024, PwC, LVMH, Orange, Toyota, LOCCITANE...) and with them raised over €5 million in donations to charities. In total, more than 3 million users in 150 countries have used United Heroes solutions. United Heroes now has 70 employees based in Paris and Madrid, and is looking to expand into other European markets.

GO CAPITAL est une société de gestion indépendante gérant des fonds d’investissement en capital-amorçage et en capital-risque pour plus de 350 M€ et intervenant dans des sociétés innovantes technologiques basées en France. GO CAPITAL a déjà financé plus de 100 sociétés innovantes depuis sa création.

Mac-Lloyd is a growing company. With a strong client base in France, Mac-Lloyd has now invested internationally to boost its growth. Mac-Lloyd is specialized in GPS tracker for Baseball, Soccer, Football, Basketball, Rugby and Ice Hockey. Based in Paris, Miami, Rosario, Auckland and Kiev.

Deloitte drives progress. Our firms around the world help clients become leaders wherever they choose to compete. Deloitte invests in outstanding people of diverse talents and backgrounds and empowers them to achieve more than they could elsewhere. Our work combines advice with action and integrity. We believe that when our clients and society are stronger, so are we. Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (“DTTL”), its global network of member firms, and their related entities. DTTL (also referred to as “Deloitte Global”) and each of its member firms are legally separate and independent entities. DTTL does not provide services to clients. Please see www.deloitte.com/about to learn more. The content on this page contains general information only, and none of Deloitte Touche Tohmatsu Limited, its member firms, or their related entities (collectively the “Deloitte Network”) is, by means of this publication, rendering professional advice or services. Before making any decision or taking any action that may affect your finances or your business, you should consult a qualified professional adviser. No entity in the Deloitte Network shall be responsible for any loss whatsoever sustained by any person who relies on content from this page.

Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM®, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, “universal” influenza candidate, OVX836, which is currently in Phase 2 clinical trials with over 1200 subjects tested and encouraging efficacy proof of concept data. Osivax’ ambition is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of sarbecovirus in one single shot. The company will expand into other infectious disease indications through combinations and collaborations worldwide.

Novolyze empowers food and beverage companies to enhance food safety and quality performance and compliance in a rapidly changing environment. We offer application-driven, tech-enabled solutions to activate a groundbreaking, holistic approach to food safety and quality. We leverage the power of IoT and cloud computing to unify food safety and quality data, transform them into actionable insights, and enable real-time decision-making.